[Pediatric neurological disorders and genetic counseling]. 2003

Yoshimitsu Fukushima
Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Nagano.

Genetic counseling provides medical and genetic information of the disease including its natural history, recurrence risk, availability and usefulness of genetic testing, as well as psycho-social support. In the field of pediatric neurology, the majority of genetic counseling seems to be a simple risk estimation of the next child and unrelated to ethical issues. However, in some cases requiring prenatal diagnosis or presymptomatic testing, we have to address serious ethical issues. Genetic counseling should be provided by an educated medical doctor at a suitable genetics clinic. In Japan, we have "Japanese Board of Medical Genetics, Clinical Geneticist" as an education system of clinical genetics for medical doctors. Pediatric neurologists should know the special issues of genetic information and contact with clinical geneticists in selected cases.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007258 Informed Consent Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment. Consent, Informed
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003219 Confidentiality The privacy of information and its protection against unauthorized disclosure. Patient Data Privacy,Privacy of Patient Data,Privileged Communication,Confidential Information,Secrecy,Communication, Privileged,Communications, Privileged,Data Privacy, Patient,Information, Confidential,Privacy, Patient Data,Privileged Communications
D005817 Genetic Counseling An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered. Counseling, Genetic,Genetic Counseling, Prenatal,Prenatal Genetic Counseling
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015997 Neonatal Screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates (INFANT, NEWBORN) from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic. Infant, Newborn, Screening,Newborn Infant Screening,Newborn Screening,Neonatal Screenings,Newborn Infant Screenings,Newborn Screenings,Screening, Neonatal,Screening, Newborn,Screening, Newborn Infant,Screenings, Neonatal,Screenings, Newborn,Screenings, Newborn Infant
D020191 Myoclonic Epilepsies, Progressive A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME. Action Myoclonus-Renal Failure Syndrome,Biotin-Responsive Encephalopathy,Dentatorubral-Pallidoluysian Atrophy,May-White Syndrome,Ataxia, Chorea, Seizures, And Dementia,Atypical Inclusion-Body Disease,Familial Progressive Myoclonic Epilepsy,Haw River Syndrome,Myoclonic Epilepsy, Progressive,Myoclonus-Nephropathy Syndrome,Naito Oyanagi Disease,Naito-Oyanagi Disease,Progressive Myoclonic Epilepsy,Progressive Myoclonus Epilepsies,Action Myoclonus Renal Failure Syndrome,Atrophies, Dentatorubral-Pallidoluysian,Atrophy, Dentatorubral-Pallidoluysian,Atypical Inclusion Body Disease,Atypical Inclusion-Body Diseases,Biotin Responsive Encephalopathy,Biotin-Responsive Encephalopathies,Dentatorubral Pallidoluysian Atrophy,Dentatorubral-Pallidoluysian Atrophies,Encephalopathies, Biotin-Responsive,Encephalopathy, Biotin-Responsive,Epilepsies, Progressive Myoclonic,Epilepsies, Progressive Myoclonus,Epilepsy, Progressive Myoclonic,Epilepsy, Progressive Myoclonus,Haw River Syndromes,Inclusion-Body Disease, Atypical,Inclusion-Body Diseases, Atypical,May White Syndrome,Myoclonus Epilepsies, Progressive,Myoclonus Nephropathy Syndrome,Myoclonus-Nephropathy Syndromes,Naito-Oyanagi Diseases,Progressive Myoclonic Epilepsies,Progressive Myoclonus Epilepsy,River Syndromes, Haw,Syndromes, Myoclonus-Nephropathy
D020388 Muscular Dystrophy, Duchenne An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415) Becker Muscular Dystrophy,Duchenne Muscular Dystrophy,Muscular Dystrophy, Becker,Muscular Dystrophy, Pseudohypertrophic,Becker's Muscular Dystrophy,Cardiomyopathy, Dilated, 3B,Cardiomyopathy, Dilated, X-Linked,Childhood Muscular Dystrophy, Pseudohypertrophic,Childhood Pseudohypertrophic Muscular Dystrophy,Duchenne and Becker Muscular Dystrophy,Duchenne-Becker Muscular Dystrophy,Duchenne-Type Progressive Muscular Dystrophy,Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type,Muscular Dystrophy, Becker Type,Muscular Dystrophy, Childhood, Pseudohypertrophic,Muscular Dystrophy, Duchenne Type,Muscular Dystrophy, Duchenne and Becker Types,Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type,Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type,Muscular Dystrophy, Pseudohypertrophic, Childhood,Progressive Muscular Dystrophy, Duchenne Type,Pseudohypertrophic Childhood Muscular Dystrophy,Pseudohypertrophic Muscular Dystrophy, Childhood,Duchenne Becker Muscular Dystrophy,Duchenne Type Progressive Muscular Dystrophy,Muscular Dystrophy, Becker's,Muscular Dystrophy, Duchenne-Becker,Pseudohypertrophic Muscular Dystrophy

Related Publications

Yoshimitsu Fukushima
January 2024, Pediatric research,
Yoshimitsu Fukushima
January 1975, Modern problems in paediatrics,
Yoshimitsu Fukushima
January 1978, Advances in oto-rhino-laryngology,
Yoshimitsu Fukushima
January 1969, Journal of the National Medical Association,
Yoshimitsu Fukushima
January 1986, Indian journal of pediatrics,
Yoshimitsu Fukushima
May 1991, Soins. Gynecologie, obstetrique, puericulture, pediatrie,
Yoshimitsu Fukushima
August 1999, Indian pediatrics,
Yoshimitsu Fukushima
June 1985, Wiener medizinische Wochenschrift (1946),
Yoshimitsu Fukushima
July 1986, Indian journal of pediatrics,
Yoshimitsu Fukushima
January 1979, Pathologica,
Copied contents to your clipboard!